Tiger Eye Capital LLC Danaher Corp Transaction History

Tiger Eye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 03, 2022	SELL	$247.06 - $1507.4 $241,377 - $1.47 Million	-977 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$212.5 - $245.46 $47,387 - $54,737	-223 Reduced 18.58%	977 $217,000
Q3 2020 Nov 13, 2020	SELL	$177.16 - $215.33 $970,305 - $1.18 Million	-5,477 Reduced 82.03%	1,200 $258,000
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $859,329 - $1.18 Million	6,677 New	6,677 $1.18 Million
Q1 2020 May 15, 2020	SELL	$121.39 - $169.05 $413,939 - $576,460	-3,410 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$133.47 - $153.48 $455,132 - $523,366	3,410 New	3,410 $523,000

2,439

563M

3.94M

4.1M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $180B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Tiger Eye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Tiger Eye Capital LLC with notifications on news.